TXMD
$5.54
Therapeuticsmd
$.01
.18%
TXMD
Earnings Whisper ®
N/A
1st Quarter March 2019
Consensus:  ($0.16)
Revenue:  N/A
Thursday
May 23
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TXMD reports earnings?
Beat
Meet
Miss

Where is TXMD's stock price going from here?
Up
Flat
Down
Stock chart of TXMD
Analysts
Summary of analysts' recommendations for TXMD
Score
Grade
Pivots
Resistance
$5.78
$5.71
$5.62

$5.55

Support
$5.46
$5.39
$5.30
Tweet
Growth
Description
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
Peers
BioMarin PharmaceuticalVertex PharmaceuticalsCelgeneInterCeptRegeneron PharmaceuticalsMylanUltragenyx PharmaceuticalJohnson & JohnsonZoetisEndo International plc